UNSPSC 51392404: Dopexamine

This classification denotes a dopamine agonist and alpha-adrenergic agonist with the molecular formula C22H32N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 398E7Z7JB5, chemically known as 1,2-benzenediol, 4-(2-((6-((2-phenylethyl)amino)hexyl)amino)ethyl)- but generally known as dopexamine, which bears US NIH Compound Identifier 55483. European Medicines Agency schedules Dopexamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06366MIG.

UNSPSC 51392404 Dopexamine is a Commodity code whose recent state and local activity centers on emergency-response pharmaceuticals and drug-management systems rather than dopexamine specifically. Seminole County, Florida's naloxone and drug deactivation procurement, posted in June 2026, illustrates the actual scope: county and regional health agencies are buying finished pharmaceutical products for community health and opioid-response programs, with quarterly delivery cycles and fixed-fee contracting. The code sees activity from county health departments and state health agencies; Seminole County's procurement is representative of the county-level buying pattern, though the Texas Health and Human Services Commission's concurrent RFI on direct-to-manufacturer prescription programs signals state-level interest in reshaping how pharmaceuticals reach public-health systems.

Recent opportunities cluster in Florida and Texas. Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2026, though the summary contains a conflicting earlier date of July 26, 2023) requires vendors to supply 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, electronic bid submission, drug-free workplace and E-Verify compliance, and fixed-fee pricing on a two-year initial term with one-year renewal option. The Texas HHS Commission's RFI (posted April 3, 2026) is exploratory rather than a formal competitive solicitation, seeking vendor input on direct-to-manufacturer prescription contracting capabilities to inform future pharmacy benefit strategy. Neither opportunity specifies set-asides for disadvantaged enterprises, and both impose federal compliance requirements (FEMA-related adherence in Seminole County; broad HHS federal regulations in Texas). The code shows limited geographic spread in recent postings; activity appears concentrated in these two states with no clear indication of broader national procurement momentum.